Searching for your content...
In-Language News
Contact Us
888-776-0942 from 8 AM - 10 PM ET
GB Sciences, Inc. (OTCQB: GBLX) announced significant preclinical results for their Parkinson's disease ("PD") formulations from the midterm report...
GB Sciences, Inc. (OTCQB: GBLX) announced the execution of a Binding Letter of Intent for the Sale of 75% of its membership interests in the...
GB Sciences, Inc. (OTCQB: GBLX) completed the sale on November 15, 2019 of its 50% membership interest in GB Sciences Louisiana, LLC to Wellcana...
GB Sciences, Inc. (OTCQB: GBLX) announces a delay in the sale of GB Sciences Louisiana LLC. On September 16, 2019, GB Sciences, Inc. (the "Company"), ...
GB Sciences, Inc. (OTCQB: GBLX) is pleased to announce that on October 23rd Mr. Edmond DeFrank joined its Board of Directors, filling a vacant seat....
GB Sciences, Inc. (OTCQB: GBLX) is featured in the October 2019 edition of the Marijuana Business Magazine. This edition...
GB Sciences, Inc. (OTCQB: GBLX), on Friday, September 13, 2019, filed an 8k announcing the sale of its 50% ownership stake in GB Sciences Louisiana,...
GB Sciences, Inc. (OTCQB: GBLX) today announced that it has received notification from the U.S. Drug Enforcement Agency (DEA) that prior to making...
GB Sciences, Inc. (OTCQB: GBLX) today announced the appointment to GB Sciences' executive team of Darin Carpenter as the company's new Executive Vice ...
GB Sciences, Inc. (OTCQB: GBLX) announced that its subsidiary GB Sciences Louisiana will hold a series of seminars in August, in partnership with...
GB Sciences Louisiana (OTCQB: GBLX) today announced that its medical cannabis products, developed in partnership with LSU AgCenter's Therapeutic...
GB Sciences, Inc. (OTCQB: GBLX), through its subsidiary, GBS Global Biopharma, Inc. ("GBS", Ottawa, CANADA), has filed a novel patent application to...
GB Sciences, Inc. (OTCQB:GBLX) today announced it has obtained an exclusive license to formulate, manufacture, and sell cannabis-infused oral thin...
GBS Global Biopharma, Inc. ("GBS Global"), a Canadian-based subsidiary of GB Sciences, Inc. (OTCQB:GBLX), announced preclinical studies on their...
GB Sciences, Inc. (OTCQB: GBLX) today announced it is nearing completion of $700,000 in power and water upgrades at its cultivation facility in Las...
GB Sciences, Inc. (OTCQB: GBLX), a partner in GB Sciences Louisiana, LLC, is announcing that all cultivation operations at LSU Agricultural Center...
GB Sciences, Inc. (OTCQB: GBLX) announced that Dr. Dominick Monaco, GB Sciences' Director of Medical Formulations, will be a featured speaker at the...
GB Sciences, Inc. (OTCQB: GBLX) today announced results from a new study that shows only three chemical varieties of cannabis were sold in the Nevada ...
GB Sciences, Inc. (OTCQB: GBLX) today announced that The LSU Agricultural Center (AgCenter) received confirmation from the Louisiana Department of...
GB Sciences, Inc. (OTCQB: GBLX) today launched a global expansion strategy with the formation of GBS Global Biopharma Inc. ("GBS Global"), a...
GB Sciences, Inc. (OTCQB: GBLX) announces that the Louisiana State University Agricultural Center (LSU AgCenter) through William B. Richardson, Vice...
GB Sciences, Inc. (OTCQB: GBLX) announced the harvest of the first test cannabis crop in the company's nationally-recognized collaboration with...
GB Sciences, Inc. (OTCQB: GBLX) announces that their first crop in the rapidly expanding hemp market expects to yield a gross profit of $0.7million...
GB Sciences, Inc. (OTCQB: GBLX) announced today that Dr. Andrea Small-Howard, Chief Science Officer and GB Sciences' Board Member, will present...
Join PR Newswire for Journalists to access all of the free services designated to make your job easier.
In need of subject matter experts for your story? Submit a free ProfNet request and find the sources you need.